Stay updated on Savolitinib Combo in EGFRm+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.

Latest updates to the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.4.2 added; the page removed the funding-lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check10 days agoChange DetectedNotice added about potential delays due to a lapse in government funding and the NIH Clinical Center's operating status. Website revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check17 days agoChange DetectedShow glossary option added; several metadata labels updated or added (Last Update Submitted that Met QC Criteria, Last Update Posted, Revision: v3.4.0) while corresponding older labels and No FEAR Act data references (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4) were removed or changed. These changes are limited to UI/metadata and do not affect core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check31 days agoChange DetectedThe revision header now shows v3.3.4 instead of v3.3.3, a minor versioning update with no impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedLocations now include California; references to California Locations and Revision: v3.3.2 were removed, with the page upgraded to Revision v3.3.3.SummaryDifference0.2%

- Check81 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2 with no changes to content, layout, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Savolitinib Combo in EGFRm+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.